Is Zyden Gentec Ltd (530091) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Zyden Gentec Ltd is a below average quality company .

What is Zyden Gentec Ltd (530091) share price return in the past 10 years?

Data is not available for this company

What is the share price of Zyden Gentec Ltd (530091)?

Company share prices are keep on changing according to the market conditions. The current trading price of Zyden Gentec Ltd (530091) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Zyden Gentec?

The latest standalone P/E ratio of Zyden Gentec as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Zyden Gentec Ltd (530091)?

The latest standalone P/B ratio of Zyden Gentec Ltd (530091) as of 01-Jan-1970 is 0.37.

What is the 52-week high and low of Zyden Gentec Ltd (530091)?

The 52-week high of Zyden Gentec Ltd (530091) is Rs. 0.95 and the 52-week low is Rs. 0.87.

Zyden Gentec Ltd (530091) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Zyden Gentec Ltd (530091)
Brand: Zyden Gentec

Zyden Gentec Ltd (530091) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Zyden Gentec Ltd (530091)

BSE: 530091 NSE:

Key Metrics

Market Cap

₹5 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.37

Price to Sales (P/S)

4.22

EV/EBITDA

-15.87

Return on Capital Employed (ROCE)

-33.84%

Current Price

₹0

Return on Equity (ROE)

-47.91%

Return on Assets (ROA)

-32.82%

Operating Profit Margin

-37.7%

Net Profit Margin

-329.3%

Gross Profit Margin

-37.6%

Book Value per Share

₹2.4

Sales Growth (YoY)

55.41%

Sales Growth (3 Years)

47.28%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹1 / 1

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

0.00%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Zyden Gentec Ltd?

Zyden Gentec Ltd revenue growth is 55.4% for FY-2019 , which is above its 5 year CAGR of -6.3% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Zyden Gentec Ltd?

Promoters hold 0.00% of the Zyden Gentec Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Zyden Gentec Ltd vs industry peers?

Zyden Gentec Ltd revenue CAGR is -6.27% , compared to the industry median CAGR of 5.54% , indicating stable growth and maintaining its market share.

Q.1 Which industry/sub-sector does Zyden Gentec Ltd belong to?

Zyden Gentec Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Zyden Gentec Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Zyden Gentec

Based on:

Data

M-Cap below 100cr DeciZen not available

Zyden Gentec stock performance

Key Ratios

Is Zyden Gentec Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	5.7%	5.5%	-14.8%	-1.4%	-1%	-0%	-1.8%	-0.1%	-3.4%	-33.8%	-
Value Creation Index ⓘ	-0.6	-0.6	-2.1	-1.1	-1.1	-1.0	-1.1	-1.0	-1.2	-3.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	17.5	12.1	9.5	7.6	1.6	0.3	0.4	0.1	0.7	1.2	1
Sales YoY Gr.	-	-30.9%	-21.4%	-20.6%	-78.9%	-78.6%	5.9%	-86.1%	1,380%	55.4%	-
Adj EPS ⓘ	0	-0	-0.7	-0.1	-0.1	-0	0.1	-0	-0.3	-0.3	-0.7
YoY Gr.	-	-200%	NA	NA	NA	NA	NA	-100%	NA	NA	-
BVPS (₹) ⓘ	3.4	3.3	2.3	2.3	2.2	2.2	2.2	2.2	1.8	1.1	2.4
Adj Net Profit ⓘ	0.1	-0.1	-4.1	-0.7	-0.3	-0	0.3	-0	-1.5	-1.4	-4
Cash Flow from Ops. ⓘ	4	-1.6	-1.8	3.7	0.3	-0	-2.4	-0.5	-5.3	0.1	-
Debt/CF from Ops. ⓘ	1	-6.2	-6.3	3.2	37.9	-4897.5	-3.3	-14.7	-0.9	23.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-26.1%	-6.3%	47.3%	55.4%
Adj EPS ⓘ	-223.1%	NA	-263%	NA
BVPSⓘ	-11.9%	-13.5%	-20.5%	-38.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	1.3	-1.2	-36.9	-5.7	-2	-0.3	2.8	-0.1	-14.2	-18.2	-39.3
Op. Profit Mgn % ⓘ	4.2	9.7	-30.5	-13.4	-81.1	-115.5	89.2	-24.2	48	-37.7	NAN
Net Profit Mgn % ⓘ	0.6	-0.9	-43	-9.7	-15.9	-12.2	96.3	-24.6	-207.5	-125.1	-328.5
Debt to Equity ⓘ	0.5	1.2	0.9	0.9	0.8	0.8	0.7	0.6	0.5	0.3	-
Working Cap Days ⓘ	183	338	543	771	3,366	15,099	15,851	1,05,065	7,402	3,641	0
Cash Conv. Cycle ⓘ	101	152	201	187	974	3,505	-6,60,636	24,427	1,861	889	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0.7	0.1
TTM Sales (₹ Cr.)	1.2	0
BVPS (₹) ⓘ	2.4	2.3
Reserves (₹ Cr.) ⓘ	2	1
P/BV ⓘ	0.37	0.39
PE ⓘ	0.00	8.56

From the Market
52 Week Low / High (₹)	0.87 / 0.95
All Time Low / High (₹)	0.16 / 35.80
Market Cap (₹ Cr.)	4.8
Equity (₹ Cr.)	11.1
Face Value (₹)	2
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

58.42

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Zyden Gentec - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	17.52	12.10	9.51	7.55	1.59	0.34	0.36	0.05	0.74	1.15
Operating Expenses ⓘ +	16.78	10.92	12.43	8.56	2.90	0.73	1.59	0.07	3.13	1.58
Manufacturing Costs	0.78	1.45	1.11	0.86	0.26	0	0	0	0	0
Material Costs	14.41	8.16	9.92	6.61	2.06	0.32	0	0.05	0.35	1.53
Employee Cost	0.74	0.87	0.99	0.76	0.36	0.04	0	0	0.01	0.01
Other Costs ⓘ	0.85	0.44	0.42	0.32	0.23	0.37	1.58	0.02	2.77	0.03
Operating Profit ⓘ	0.74	1.18	-2.92	-1.01	-1.31	-0.39	-1.23	-0.01	-2.39	-0.43
Operating Profit Margin (%)	4.2%	9.7%	-30.7%	-13.4%	-82.2%	-115.0%	-345.0%	-24.2%	-322.0%	-37.7%
Other Income ⓘ +	0.09	0.02	0.11	0.94	1.33	0.38	0.86	0	1.88	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-0.05	-3.34
Interest ⓘ	0.47	0.90	1.24	0.40	0.03	0.03	0	0	1.62	0
Depreciation ⓘ	0.17	0.32	0.41	0.26	0.25	0	0	0	0	0
Profit Before Tax ⓘ	0.20	-0.02	-4.46	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
Tax ⓘ	0.08	0.08	-0.36	0	0	0	0	0	0	0
Profit After Tax	0.12	-0.11	-4.10	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
PAT Margin (%)	0.7%	-0.9%	-43.1%	-9.7%	-16.6%	-12.2%	-103.0%	-24.6%	-294.0%	-329.0%
Adjusted EPS (₹)	0.1	-0.0	-0.7	-0.1	-0.1	-0.0	-0.1	0.0	-0.4	-0.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	8.58	8.47	12.97	12.63	12.36	12.32	11.95	11.94	9.76	5.98
Share Capital ⓘ	5.07	5.07	11.11	11.11	11.11	11.11	11.11	11.11	11.11	11.11
Reserves ⓘ	3.52	3.41	1.85	1.52	1.25	1.21	0.84	0.83	-1.36	-5.13
Debt +	3.93	9.57	10.70	7.07	5.41	5.17	4.11	4.51	4.54	2.01
Long Term Debt	3.93	2.95	4.33	0	0	0	0	0	0	0
Short Term Debt	0	6.61	6.38	7.07	5.41	5.17	4.11	4.51	4.54	2.01
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	2.77	1.75	1.07	1	1.55	1.21	0.97	0.97	0.08	0.06
Others Liabilities ⓘ	0.44	2.63	1.65	5.60	5.15	4.98	3.94	3.34	0.47	0.07
Total Liabilities ⓘ	15.73	22.42	26.39	26.30	24.47	23.69	20.98	20.75	14.85	8.12
Fixed Assets
Net Fixed Assets ⓘ +	3.70	8.97	8.75	8.53	8.25	8.25	5.33	5.33	0.05	0.05
Gross Block	4.25	9.83	10.02	10.05	9.99	9.99	7.07	7.06	0.07	0.07
Accumulated Depreciation	0.54	0.86	1.27	1.52	1.74	1.74	1.74	1.74	0.02	0.02
CWIP ⓘ	0.62	0.08	0.08	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0.01	0.01	0	0	0	0	0
Inventories	2.92	5.99	2.53	1.27	0.69	0.69	0.69	0.69	0.69	0
Trade Receivables	3.94	3.09	2.15	4.69	4.69	4.11	3.84	4.04	4.31	0.73
Cash Equivalents	0.20	0.25	0.11	0.12	0.03	0.15	0.03	0.10	0.03	0
Others Assets ⓘ	4.34	4.05	12.79	11.68	10.80	10.48	11.09	10.60	9.77	7.35
Total Assets ⓘ	15.73	22.42	26.39	26.30	24.47	23.69	20.98	20.75	14.85	8.12

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	3.98	-1.61	-1.78	3.69	0.26	-0	-2.36	-0.50	-5.33	0.09
PBT ⓘ	0.20	-0.02	-4.46	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
Adjustment ⓘ	1.07	1.12	1.54	-0.27	-1.03	-0.35	0.69	0	0.87	-0
Changes in Working Capital ⓘ	2.74	-2.67	1.15	4.69	1.55	0.39	-2.12	-0.49	-4.01	3.86
Tax Paid ⓘ	-0.02	-0.03	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-4.68	-4.25	-6.44	0.35	1.34	0.39	2.24	0.50	5.45	2.41
Capex	-0.80	-5.03	-0.20	-0.04	0.02	0	1.91	0	0	-0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-3.88	0.79	-6.24	0.39	1.33	0.39	0.33	0.50	5.45	2.42
Cash Flow From Financing Activity ⓘ +	0.85	5.91	8.08	-4.03	-1.69	-0.27	-0	0.07	-0.19	-2.53
Net Proceeds from Shares ⓘ	0.34	0.60	8.10	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	2.78	1.37	-4.33	0	0	0	0.07	0	0
Interest Paid ⓘ	-0.42	-0.82	-1.16	-0.39	-0.03	0	0	0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.94	3.35	-0.24	0.69	-1.65	-0.27	-0	-0	-0.18	-2.53
Net Cash Flow ⓘ	0.16	0.05	-0.14	0.01	-0.09	0.11	-0.12	0.07	-0.07	-0.03

Finance Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	1.54	-1.27	-38.24	-5.71	-2.12	-0.34	-3.04	-0.11	-20.13	-47.91
ROCE (%)	5.69	5.54	-14.83	-1.36	-0.99	-0.04	-1.75	-0.07	-3.36	-33.84
Asset Turnover Ratio	1.37	0.69	0.42	0.32	0.07	0.02	0.02	0	0.04	0.1
PAT to CFO Conversion(x)	33.17	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	75	98	93	150	934	4,223	4,077	0	2,054	803
Inventory Days	63	124	151	83	195	664	710	4,700	341	0
Payable Days	41	101	52	57	226	1,593	0	7,010	543	17

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zyden Gentec Ltd FAQs

The current trading price of Zyden Gentec on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zyden Gentec stood at ₹4.83 Cr

The latest P/E ratio of Zyden Gentec as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Zyden Gentec as of 31-Dec-1969 is 0.37.

The 52-week high of Zyden Gentec is ₹0.95 and the 52-week low is ₹0.87.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zyden Gentec is ₹1.15 ( Cr.) .

About Zyden Gentec Ltd

Zyden Gentec was incorporated on April 26, 1994 under the companies Act 1956 as Overseas Capital Private Limited. The name of the company was changed to Overseas Capital Limited on conversion into public limited company on November 11, 1994 and to Zyden Gentec Limited on July 16, 2004. The company was promoted by RK Dhar.

Initially the company was engaged in providing financial services and is presently engaged in the manufacturing of pharmaceuticals and fine chemicals.

Product range of the company includes:

The company's principal activity is to manufacture pharmaceutical products and to provide concultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates

Drotaverine HCL
Levocetrizine
Ketoconazole
Sildenafil Citrate
Glucosamine
Ciprofloxacin HCL
Enro Floxacin
Bypyridine
Guaifenesin

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Zyden Gentec Ltd (530091) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating